These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20521434)

  • 41. Risk charts--very popular but useless?
    Sinzinger H; Derfler K; Laimer H; Seyfried H; Maier M
    Vasa; 2010 Nov; 39(4):287-9. PubMed ID: 21186690
    [No Abstract]   [Full Text] [Related]  

  • 42. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
    Lin KJ; De Caterina R; García Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.
    Al-Sofiani ME; Derenbecker R; Quartuccio M; Kalyani RR
    Curr Diab Rep; 2019 Sep; 19(10):107. PubMed ID: 31544224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspirin overprescription in primary cardiovascular prevention.
    Manes C; Giacci L; Sciartilli A; D'Alleva A; De Caterina R
    Thromb Res; 2006; 118(4):471-7. PubMed ID: 16321425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.
    Hopper I; Billah B; Skiba M; Krum H
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):813-23. PubMed ID: 21878448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aspirin for primary prevention of cardiovascular events in people with diabetes.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
    [No Abstract]   [Full Text] [Related]  

  • 48. Why P is not perfect.
    Chopra V; Hayward RA
    Am J Med; 2012 Jun; 125(6):e1-2. PubMed ID: 22483057
    [No Abstract]   [Full Text] [Related]  

  • 49. Multi-constituent cardiovascular pills (MCCP)--challenges and promises of population-based prophylactic drug therapy for prevention of heart attack.
    Jamieson MJ; Naghavi M
    Curr Pharm Des; 2007; 13(10):1069-76. PubMed ID: 17430169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
    Krane V; Wanner C
    Am J Kidney Dis; 2005 Mar; 45(3):607-9. PubMed ID: 15754285
    [No Abstract]   [Full Text] [Related]  

  • 51. Aspirin in the primary prevention of cardiovascular disease.
    Galloway CF; Stevenson JC
    Maturitas; 2011 Jan; 68(1):3-4. PubMed ID: 21111550
    [No Abstract]   [Full Text] [Related]  

  • 52. Primary prevention of myocardial infarction: putting the evidence to use.
    Herzog E; Javed F
    Arch Intern Med; 2010 Aug; 170(15):1381-2. PubMed ID: 20696965
    [No Abstract]   [Full Text] [Related]  

  • 53. Appropriate aspirin use for primary prevention of cardiovascular disease.
    Miser WF
    Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
    [No Abstract]   [Full Text] [Related]  

  • 54. A national survey on aspirin patterns of use and persistence in community outpatients in Italy.
    Filippi A; Bianchi C; Parazzini F; Cricelli C; Sessa E; Mazzaglia G
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):695-703. PubMed ID: 21450601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.
    Tanaka M; Ishii H; Aoyama T; Takahashi H; Toriyama T; Kasuga H; Takeshita K; Yoshikawa D; Amano T; Murohara T
    Atherosclerosis; 2011 Dec; 219(2):643-7. PubMed ID: 22018643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS; Silverman SH; Lip GY
    Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
    [No Abstract]   [Full Text] [Related]  

  • 57. [Aspirin for primary cardiovascular prevention : the end of an era ?].
    Ravach G; Fournier S; Mazzolai L; Nanchen D
    Rev Med Suisse; 2020 Mar; 16(684):459-462. PubMed ID: 32134226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspirin for the prevention of cardiovascular disease.
    Lin KW
    Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
    [No Abstract]   [Full Text] [Related]  

  • 59. Nutraceuticals in the early infancy.
    Pignatelli P; Basili S
    Cardiovasc Ther; 2010 Aug; 28(4):236-45. PubMed ID: 20553293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
    Waltering A; Hemkens L; Florack C
    Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.